INNOVATIONS IN ARTIFICIAL INTELLIGENCE

Monday, March 10, 2025

8:00 AM – 9:00 AM ET

Moderator(s)

Rafael Beyar, MD, DSc, MPH

Interventional cardiologists and President
Rambam Hospital/ Rambam Friends Organizations
Haifa, Israel

Disclosure(s): Bio-T: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cuspa medical: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medhub AI: Stock-privately held company (Ongoing)
Mona Advani, M.Sc., MBA

Principal Regulatory Consultant
CardioMed Device Consultants
HERNDON, Virginia, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Tony Das, MD

System Chief, Business Development and Strategy. Medical Director, Endovascular Therapy, Digital Health and Innovation
Baylor Scott & White The Heart Hospital - Plano, Texas, United States

Disclosure(s): ,Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Cordis, Endovascular Division: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing)
Yair Feld, MD, PhD

Director -Interventional cardiology
Tzafon Medical Center (Poriya), Israel

Disclosure(s): No financial relationships to disclose
NG

Nicolas Gausserand, MD

Disclosure information not submitted.
David F. Kong, MD, AM, DMT

Associate Professor of Medicine
Duke University
Durham, North Carolina, United States

Disclosure(s): International Business Machines: Grant/Research Support (Ongoing)
Ran Kornowski, MD

Chairman, Department of Cardiology
Rabin Medical Center
Petach-Tikva, Israel

Disclosure(s): Medtronics-Cathworks: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Michael Leasure

Co-founder/President
HEARTio

Disclosure(s): Heart Input Output Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Taylor Becker, PhD

Researcher
The Ohio State University College of Medicine

Disclosure(s): DASI Simulations: Consultant (Ongoing); Inventor on patents regarding computational modeling: Patents issued and filed (Ongoing)

Disclosure(s):

Rafael Beyar, MD, DSc, MPH: Bio-T: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cuspa medical: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medhub AI: Stock-privately held company (Ongoing)

Mona Advani, M.Sc., MBA: No financial relationships to disclose

Tony Das, MD: ,Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Cordis, Endovascular Division: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing)

Yair Feld, MD, PhD: No financial relationships to disclose

David F. Kong, MD, AM, DMT: International Business Machines: Grant/Research Support (Ongoing)

Ran Kornowski, MD: Medtronics-Cathworks: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Michael Leasure: Heart Input Output Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Taylor Becker, PhD: DASI Simulations: Consultant (Ongoing); Inventor on patents regarding computational modeling: Patents issued and filed (Ongoing)